Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD79a antibody (AA 202-216)

This anti-CD79a antibody is a Mouse Monoclonal antibody detecting CD79a in FACS, IF and WB. Suitable for Human.
Catalog No. ABIN7127228

Quick Overview for CD79a antibody (AA 202-216) (ABIN7127228)

Target

See all CD79a (CD79A) Antibodies
CD79a (CD79A) (B-cell antigen receptor complex-associated protein alpha chain (CD79A))

Reactivity

  • 222
  • 109
  • 89
  • 66
  • 65
  • 47
  • 29
  • 27
  • 27
  • 27
  • 17
  • 10
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
Human

Host

  • 122
  • 108
  • 1
  • 1
Mouse

Clonality

  • 156
  • 75
  • 1
Monoclonal

Conjugate

  • 102
  • 17
  • 16
  • 12
  • 11
  • 11
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD79a antibody is un-conjugated

Application

  • 150
  • 101
  • 98
  • 92
  • 47
  • 38
  • 24
  • 22
  • 22
  • 13
  • 9
  • 6
  • 5
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Western Blotting (WB)
  • Binding Specificity

    • 86
    • 16
    • 10
    • 10
    • 8
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 202-216

    Specificity

    A disulphide-linked heterodimer, consisting of mb-1 (or CD79a) and B29 (or CD79b) polypeptides, is non-covalently associated with membrane-bound immunoglobulins on B cells. This complex of mb-1 and B29 polypeptides and immunoglobulin constitute the B cell Ag receptor. CD79a first appears at pre B cell stage, early in maturation, and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in the majority of acute leukemias of precursor B cell type, in B cell lines, B cell lymphomas, and in some myelomas. It is not present in myeloid or T cell lines. Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20). This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein.

    Isotype

    IgG3
  • Application Notes

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL),Optimal dilution for a specific application should be determined.

    Positive_Control: Daudi or Ramos cells. Germinal center B- cells in a lymph node or tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    CD79a (CD79A) (B-cell antigen receptor complex-associated protein alpha chain (CD79A))

    Alternative Name

    CD79A

    Background

    B lymphocyte-specific MB1 protein, B-cell antigen receptor complex-associated protein alpha chain, CD79a molecule immunoglobulin associated alpha, Ig-alpha, IGA, IgM-alpha, Immunoglobulin-associated alpha, Ly54, MB-1 membrane glycoprotein, Membrane-bound immunoglobulin-associated protein, Surface IgM-associated protein,CD79a (B-Cell Marker)
    Cellular localisation: Cell surface

    Molecular Weight

    25-44kDa

    Gene ID

    973, 631567

    UniProt

    P11912

    Pathways

    BCR Signaling
You are here:
Chat with us!